Virchow Biotech




Mega Lifesciences
Concise Prescribing Info
Teriparatide [r-human parathyroid hormone (1-34)]
Postmenopausal women w/ osteoporosis at high risk for fracture. Increase of bone mass in men w/ primary or hypogonadal osteoporosis at high risk for fracture. Osteoporosis associated w/ sustained systemic glucocorticoid therapy at high risk for fracture.
Dosage/Direction for Use
SC 20 mcg once daily. Treatment duration: Not >2 yr.
Hypersensitivity. Preexisting hypercalcaemia; metabolic bone diseases other than primary osteoporosis (including hyperparathyroidism & Paget's disease of bone); unexplained elevations of alkaline phosphatase; prior external beam or implant radiation therapy to the skeleton; patients w/ skeletal malignancies or bone metastases. Severe renal impairment.
Special Precautions
Not to be prescribed for patients at increased baseline risk for osteosarcoma including those w/ Paget's disease of bone or unexplained elevations of alkaline phosphatase, or prior external beam or implant radiation therapy involving the skeleton. Isolated episodes of transient orthostatic hypotension. May increase urinary Ca excretion. Patients w/ active or recent urolithiasis; hepatic, renal & cardiac disease. Concomitant use w/ digitalis. Refrain from driving or the use of machines until symptoms (eg, transient, orthostatic hypotension or dizziness) have subsided. Moderate renal impairment. Not to be used during pregnancy & lactation, in ped patients or young adults w/ open epiphyses.
Adverse Reactions
Pain in limb. Nausea, dizziness, headache. Anemia; hypercholesterolemia; depression; sciatica; vertigo; palpitation; hypotension; dyspnea; vomiting, hiatus hernia, GERD; increased sweating; muscle cramps; fatigue, chest pain, asthenia.
Drug Interactions
Increased serum Ca in concomitant use w/ digoxin.
MIMS Class
Agents Affecting Bone Metabolism
ATC Classification
H05AA02 - teriparatide ; Belongs to the class of parathyroid hormones and analogues. Used in the management of calcium homeostasis.
MEGAPTH inj 750 mcg/3 mL
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in